Emtriva

Gilead Advancing Access Patient Assistance Program Patient Guide: How to Get Emtriva (emtricitabine) at Low or No Cost

Emtriva (emtricitabine) is a prescription medication used to treat HIV infection in adults and children. The Gilead Advancing Access Patient Assistance Program helps eligible uninsured or underinsured patients get Emtriva free of charge if you meet income and other requirements.

About Emtriva (emtricitabine)

Emtriva is an antiviral medicine that belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs). It works by slowing the spread of HIV in the body, helping to control the infection and reduce the risk of complications. Emtriva is often used as part of a combination therapy with other HIV medications. It comes in capsule or oral solution forms and is taken once daily. Common side effects may include headache, diarrhea, nausea, and skin discoloration on the palms or soles. Always take it exactly as prescribed by your doctor, and never stop without medical advice. This program focuses on access, not medical advice—discuss your treatment with your healthcare provider.

Who Qualifies for the Program?

The Gilead Advancing Access Patient Assistance Program (PAP/MAP) is designed for uninsured or underinsured U.S. residents (including Puerto Rico and U.S. Territories) who cannot afford their Gilead medications like Emtriva. You must:

• Live in the U.S., Puerto Rico, or U.S. Territories (proof of residency required).
• Have household income at or below 500% of the Federal Poverty Level (FPL).
• Be uninsured or underinsured (no or limited prescription coverage).
• Have a valid prescription for Emtriva from a licensed U.S. healthcare provider.

Enrollment lasts up to 12 months, with ongoing eligibility checks. If your situation changes (e.g., you get insurance), you may no longer qualify.

Income Eligibility Breakdown

Eligibility is based on your total household income compared to 500% of the FPL. Use the table below for 2026 guidelines (FPL adjusts annually; confirm current levels when applying).

Add about $26,340 per additional family member. These are estimates at 500% FPL. Provide proof like tax returns, W-2s, or pay stubs. Program specialists verify during enrollment.

Insurance Requirements

This program is for uninsured or underinsured patients. 'Uninsured' means no prescription coverage. 'Underinsured' means coverage doesn't cover Emtriva fully (e.g., high copays). Medicare patients may qualify if underinsured, but check specifics—program excludes those with adequate commercial insurance. Disclose all insurance, including ADAP or other assistance. Gilead may investigate benefits.

Step-by-Step Application Process

1. Get a Prescription: Ask your doctor for Emtriva prescription. They must sign the enrollment form.

2. Choose Application Method (multiple options):

   • Call: Dial (800) 226-2056 (Mon-Fri, 9 AM–8 PM ET) for help from a specialist.
   • Download & Fax: Get the English or Spanish enrollment form from GileadAdvancingAccess.com. Fax to the number on the form (e.g., 1-800-216-6857).
   • Online: Enroll at the website for possible immediate eligibility check.
   • Doctor can use HCP portal.

3. Complete the Form: Include patient info, income, insurance details, prescription. Sign it; doctor signs too. Authorize info sharing for verification.

4. Gather Documents:

   • Proof of income (tax return, W-2, last two pay stubs).
   • Proof of residency (ID, utility bill).
   • Prescription.
   • Proof of identity if requested.

5. Submit: Fax, online, or call. Expect a call from a specialist for next steps.

6. Review: Forms reviewed in ~2 business days. You'll be notified by phone/email (list preferred contact).

Timeline and Delivery

• Processing: 2 business days for review; immediate online sometimes.
• Approval Notification: Call or preferred method.
• Delivery: Medication shipped free to your home or doctor's office via a specialty pharmacy.
• Supply: Up to 12 months, with reauthorization.

Alternatives if Denied

• Appeal: Contact (800) 226-2056 to discuss reasons (e.g., income too high) and resubmit.
• Co-pay Program: For commercially insured.
• State ADAP: Apply for AIDS Drug Assistance Program.
• Other PAPs: Check NeedyMeds.org or RxAssist.org.
• Generic Options: No biosimilars listed; discuss with doctor.
• Manufacturer Copay Cards: If insured.

Reauthorization

Reauthorization is required. Before 12 months end, submit updated form/docs to confirm ongoing eligibility (income, residency, insurance). Program checks periodically.

Important Disclaimer

This guide is for informational purposes based on program details as of 2026. Gilead can change, modify, or end the program anytime without notice. Eligibility not guaranteed. Not medical/financial advice—consult your doctor and call (800) 226-2056 for personalized help. Income/FPL based on household size; verify current FPL at ASPE.hhs.gov. Protect your info; only share as authorized.